News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Richard A. Rudick Joins Biogen Idec, Inc. (Massachusetts) (BIIB) As Vice President, Development Sciences, Value-Based Medicine


5/12/2014 7:09:37 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Biogen Idec (NASDAQ: BIIB) today announced that Richard (Rick) A. Rudick, M.D., has joined the company as vice president, Development Sciences, Value-Based Medicine.

Dr. Rudick will lead Biogen Idec’s newly created Value-Based Medicine Group, which will focus on using new technology to develop innovative programs and tools to better understand, measure and manage the treatment of multiple sclerosis (MS).

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES